Gut Microbiota Predict Efficacy of Neoadjuvant Systemic Therapy in Patients with Early Breast Cancer

Purpose: The gut microbiome has been shown to influence the efficacy of some systemic anti-cancer therapies. This prospective study explored the ability of the pre-treatment gut microbiome to predict pathological complete response (pCR) in patients receiving neoadjuvant chemotherapy (NACT) for early breast cancer.

Source: Clinical Oncology - March 8, 2024 Category: Radiology Authors: K. Ross, B. Nichols, R. Papadopoulou, M. Macleod, J. Fraser, S. Barrett, K. Teo, E. Mallon, A. Ammar, J. Edwards, J. Evans, K. Gerasimidis, I. Macpherson Source Type: research